{"id":969,"date":"2025-03-10T10:57:57","date_gmt":"2025-03-10T13:57:57","guid":{"rendered":"https:\/\/oncobiomed.cl\/?post_type=noticias&#038;p=969"},"modified":"2025-03-10T13:25:34","modified_gmt":"2025-03-10T16:25:34","slug":"universidad-de-chile","status":"publish","type":"noticias","link":"https:\/\/oncobiomed.cl\/en\/noticias\/universidad-de-chile\/","title":{"rendered":"Universidad de Chile"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">A therapeutic vaccine developed at the University of Chile will be tested on patients with gallbladder cancer in Valdivia. Region de los Rios concentrates the highest number of diagnosed cases globally.<\/span><\/p>","protected":false},"featured_media":975,"template":"","class_list":["post-969","noticias","type-noticias","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/noticias\/969","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/types\/noticias"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/media\/975"}],"wp:attachment":[{"href":"https:\/\/oncobiomed.cl\/en\/wp-json\/wp\/v2\/media?parent=969"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}